SCHEMBL2819604

SCHEMBL2819604

CCCc1ccc(OC(=O)c2ccccc2)c(OC)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.67
MEN1 O00255 2/20 0.67
CYP3A4 P08684 1/20 0.67
TDP1 Q9NUW8 1/20 0.67
L3MBTL1 Q9Y468 1/20 0.67
ADRB2 P07550 2/20 0.54
ADRB1 P08588 2/20 0.54
ADRB3 P13945 2/20 0.54
ALDH1A1 P00352 4/20 0.53
SMN1; SMN2 Q16637 3/20 0.53
NPC1 O15118 2/20 0.53
RAB9A P51151 2/20 0.53
POLB P06746 1/20 0.53
SYK P43405 1/20 0.52
VCP P55072 1/20 0.52
MAPK1 P28482 1/20 0.52
HPGD P15428 2/20 0.51
ALOX12 P18054 1/20 0.51
MAPT P10636 3/20 0.50
HTT P42858 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2506153 0.93 KMT2A (0.57) KMT2AMEN1CYP3A4TDP1L3MBTL1
SCHEMBL23639738 0.90 KMT2A (0.72) KMT2AMEN1CYP3A4TDP1L3MBTL1
SCHEMBL31321630 0.90 KMT2A (0.72) KMT2AMEN1CYP3A4TDP1L3MBTL1
SCHEMBL17951283 0.86 KMT2A (0.64) KMT2AMEN1CYP3A4TDP1L3MBTL1
SCHEMBL16610045 0.85 KMT2A (0.71) KMT2AMEN1CYP3A4TDP1L3MBTL1
SCHEMBL2815601 0.85 PPARG (0.53) KMT2AMEN1CYP3A4TDP1L3MBTL1
SCHEMBL22406315 0.85 KMT2A (0.63) KMT2AMEN1CYP3A4TDP1L3MBTL1
SCHEMBL2502958 0.84 KMT2A (0.54) KMT2AMEN1CYP3A4TDP1L3MBTL1
SCHEMBL9340141 0.84 KMT2A (0.69) KMT2AMEN1CYP3A4TDP1L3MBTL1
SCHEMBL4733370 0.83 SERPINE1 (0.55) KMT2AMEN1CYP3A4TDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10869822-B2 Compositions for treatment of dermatological diseases and conditions and methods of use thereof DermaMedics, LLC (US) 2020-12-22 US disclosed
US-20180235859-A1 Compositions for Treatment of Dermatological Diseases and Conditions and Methods of Use Thereof DermaMedics, LLC 2018-08-23 US disclosed
US-9980887-B2 Compositions for use in treatment of hyperpigmentation and methods of use thereof DermaMedics, LLC (US) 2018-05-29 US disclosed
EP-3238696-A1 METHODS AND COMPOSITIONS FOR TREATING DERMATOLOGICAL DISEASES AND CONDITIONS Therametics, Llc (US) 2017-11-01 EP disclosed
US-9622950-B2 Compositions for use in treatment of dermatological diseases and conditions DermaMedics, LLC (US) 2017-04-18 US disclosed
US-9616006-B2 Methods and compositions for treating dermatological diseases and conditions DermaMedics, LLC (US) 2017-04-11 US disclosed
US-20160346180-A1 Compositions for Use in Treatment of Dermatological Diseases and Conditions and Methods of Use Thereof DERMAMEDICS LLC (US) 2016-12-01 US disclosed
US-20130289006-A1 COMPOSITIONS FOR TREATING HYPERPIGMENTATION AND METHODS OF USE THEREOF DermaMedics, LLC 2013-10-31 US disclosed
US-20130281411-A1 COMPOSITIONS FOR TREATING INFLAMMATORY DERMATOLOGICAL DISEASES AND CONDITIONS AND METHODS OF USE THEREOF DermaMedics, LLC 2013-10-24 US disclosed
US-20130280195-A1 COMPOSITIONS FOR USE IN TREATMENT OF DERMATOLOGICAL DISEASES AND CONDITIONS AND METHODS OF USE THEREOF DermaMedics, LLC 2013-10-24 US disclosed
US-20130274231-A1 COMPOSITIONS FOR USE IN TREATMENT OF DERMATOLOGICAL DISEASES AND CONDITIONS DermaMedics, LLC 2013-10-17 US disclosed
EP-2244690-A1 METHODS AND COMPOSITIONS FOR TREATING DERMATOLOGICAL DISEASES AND CONDITIONS Therametics, Llc (US) 2010-11-03 EP disclosed
US-20100249244-A1 METHODS AND COMPOSITIONS FOR TREATING DERMATOLOGICAL DISEASES AND CONDITIONS THERAMETICS, LLC 2010-09-30 US disclosed
WO-2009049172-A1 METHODS AND COMPOSITIONS FOR TREATING DERMATOLOGICAL DISEASES AND CONDITIONS THERAMETICS, LLC (US) 2009-04-16 WO disclosed